Other Clinical Trial - Role of K+ & Ca2+ in Development of NCT02712658

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Clinical Trial Details — Status: Completed

The aim of the study is to investigate the role of K+ and Ca2+ in development of muscle fatigue in trained young men.

Recruitment information / eligibility
Status	Completed
Enrollment	10
Est. completion date	March 2016
Est. primary completion date	March 2016
Accepts healthy volunteers	Accepts Healthy Volunteers
Gender	Male
Age group	18 Years to 40 Years
Eligibility	Inclusion Criteria: - physical active healthy men - aged 18-40 years Exclusion Criteria: - smokers - allergy towards terbutaline - chronic disease

Drug:
• Terbutaline
K+ transport and Ca2+ release and uptake function are stimulated by administration of terbutaline
• Placebo

Locations
Country	Name	City	State
Denmark	Department of Nutrition, Exercise and Sports	Copenhagen

Sponsors *(1)*
Lead Sponsor	Collaborator
University of Copenhagen

Denmark,

Outcome
Type	Measure	Description	Time frame	Safety issue
Primary	Change in time to fatigue during knee-extensor exercise		1 day